Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-003272
Filing Date
2024-10-11
Accepted
2024-10-11 16:01:11
Documents
6
Period of Report
2024-10-11

Document Format Files

Seq Description Document Type Size
1 6-K zk2432124.htm 6-K 11187
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 114795
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 24595
4 image0.jpg GRAPHIC 33267
5 image00002.jpg GRAPHIC 376074
6 image2.jpg GRAPHIC 613930
  Complete submission text file 0001178913-24-003272.txt   1561147
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 241367526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)